Synonyms: SAR97276 | SAR97276A | T3
Compound class:
Synthetic organic
Comment: Albitiazolium was the clinical lead from the bisthiazolium series, a novel class of choline analogue with potent antimalarial activity [2-3].
We display the structure of the parent compound, with PubChem and ChEMBL links provided in the table below. However, the INN-assigned compound is in complex with bromide (represented in PubChem CID 11377022) and this compound is used in the experimental data listed under the 'biological activity' tab. The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
Guide to Malaria Pharmacology Comments |
Potential Target/Mechanism Of Action: As the precise mechanism of action of albitiazolium in the malaria parasite is not yet known, we do not have a Plasmodium molecular target for this compound. Further information about possible mechanistic insights is provided under the Clinical data tab. |